Resources from the same session
4221 - Natural history of sarcomas and impact of reference centers in the nationwide NETSARC study on 35,784 patients (pts) from 2010 to 2017.
Presenter: Jean-Yves Blay
Session: Proffered paper session - Sarcoma
Resources:
Abstract
Slides
Webcast
638 - Outcome following unplanned excision in soft tissue sarcoma. Results of a multicentre study including 728 patients.
Presenter: Maria Smolle
Session: Proffered paper session - Sarcoma
Resources:
Abstract
Slides
Webcast
983 - A phase II/III trial of hafnium oxide nanoparticles activated by radiotherapy in the treatment of locally advance soft tissue sarcoma of the extremity and trunk wall
Presenter: Sylvie Bonvalot
Session: Proffered paper session - Sarcoma
Resources:
Abstract
Slides
Webcast
Proffered paper session - Sarcoma - Invited Discussant 1601O, 1602O and LBA66
Presenter: Rick L. Haas
Session: Proffered paper session - Sarcoma
Resources:
Slides
Webcast
4816 - Initial Results of Phase 1 Study of DCC-2618, a Broad-spectrum KIT and PDGFRa Inhibitor, in Patients (pts) with Gastrointestinal Stromal Tumor (GIST) by Number of Prior Regimens.
Presenter: Suzanne George
Session: Proffered paper session - Sarcoma
Resources:
Abstract
Slides
Webcast
6067 - Cabozantinib in Patients With Advanced Osteosarcomas and Ewing sarcomas: a French Sarcoma Group (FSG)/ US National Cancer Institute phase II collaborative study.
Presenter: Antoine Italiano
Session: Proffered paper session - Sarcoma
Resources:
Abstract
Slides
Webcast